Sugar Editorial Picks
Oct 07, 2008 -
The other day I came across an online store that carries cucumber molds. Apparently, cucumbers can now be sliced into cute hearts, stars, and other shapes. Seeing this new Japanese invention reminded me of the square watermelon, another fruit mold designed in Japan to make watermelon easier to stack and store.
- 17 Comments
Other Search Results
Sep 24, 2009 -
I gaze out past the middle finger of my left hand into the Hollywood Hills as my right quad quivers holding Warrior 2. This is when Bob Harper, trainer from The Biggest Loser, says, "You might be feeling a bit of heat in your thigh right about now." He's teaching a yoga class to a few bloggers and ladies of the press, and we all laugh as our legs burn.
- 7 Comments
Sep 03, 2009 -
What does every teacher get on the first day of school? An apple. Smiling faces would be more than enough for any educator, but parents often usher them in with a less than shiny fruit that ends up in the teacher's lounge.
- 17 Comments
Aug 10, 2009 -
Everyone knows I am crazy for popsicles — there's no better way to beat the heat on a Summer day. Although avocado is generally used in savory dishes like guacamole, it is a fruit and therefore is perfect for dessert!
These avocado coconut creamsicles are surprisingly delicious and decadent.
- 17 Comments
Dec 05, 2006 -
In most cases mold is just a nuisance. While most molds prefer warmer temperatures, they can grow in the colder range. Molds also tolerate salt and sugar better than most other food invaders, which is why you may find mold in refrigerated jams and jellies and on cured, salty meats - ham, bacon and salami.
- 1 Comment
Jun 10, 2009 -
Money is tight these days, so after spending your hard-earned cash on nutritious produce, don't just toss it in the fridge willy-nilly. Use these tips on storing your produce so your fruits and veggies last until you're ready to enjoy them.
Broccoli, cauliflower, radishes, celery, corn, carrots, and scallions: Store these in separate plastic bags.
- 13 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Other Treatments
- Decongestants
- Antihistamines
- Corticosteroids
- Immunotherapy
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
Ciclesonide (Omanaris), a corticosteroid nasal spray, has been approved for treatment of seasonal and perennial allergic rhinitis (hay fever) in adults and children age 12 years and older.
FDA Drug Warnings
- The antihistamine promethazine (Phenergan) should not be given to children younger than age 2 because it may cause serious breathing problems.
- Omalizumab (Xolair) may cause a life-threatening allergic reaction (anaphylaxis). This drug is used to treat allergy-related asthma, but is also being investigated as an allergy treatment.
Cough and Cold Medicines for Children
In 2007, the FDA began reviewing the safety and effectiveness of cough and cold medicines for children.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- Causes
- Risk Factors
- Diagnosis
- Prevention
- Treatment
- Other Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Allergic rhinitis is an allergic reaction that occurs when your immune system overreacts to substances that you have inhaled (often pollen). The two types of allergic rhinitis are seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis, which occurs year-round. Hay fever is caused by outdoor allergens, and perennial allergic rhinitis by indoor allergens (such as dust mites, pet dander, mold).
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Causes
- Prognosis
- Risk Factors
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Omalizumab is approved for patients who have moderate-to-severe asthma related to allergies and whose symptoms are not controlled by inhaled corticosteroids. It is given by injection in a doctor’s office every 2 - 4 weeks.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Prognosis
- Risk Factors
- Symptoms
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Health care providers need to carefully observe patients for 2 hours after they receive an omalizumab injection. However, because an allergic reaction can occur up to 24 hours after the injection, patients need to know the signs and symptoms of anaphylaxis and how to self-administer emergency treatment.
- 0 Comments